Fred W. Sabb

Oregon Research Institute — United States

Neuroscience · Life Sciences

20h-index3.7kcitations48works7.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Functional Brain Connectivity Studies(19), Schizophrenia research and treatment(13), Neural and Behavioral Psychology Studies(9), Bipolar Disorder and Treatment(7), Mental Health Research Topics(6)

Publications48 total

Sample Ascertainment and Recruitment Sources in the Accelerating Medicines Partnership Schizophrenia Program
UNC Libraries·2025Open Access
Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample
UNC Libraries·2025Open Access
Sample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia Program
UNC Libraries·2025Open Access
Baseline Clinical Characterization of Participants in the Accelerating Medicines Partnership Schizophrenia Program
UNC Libraries·2025Open Access
The electroencephalography protocol for the Accelerating Medicines Partnership® Schizophrenia Program: Reliability and stability of measures
Schizophrenia·2025· 3 citedOpen Access
Digital health technologies in the accelerating medicines Partnership® Schizophrenia Program
Schizophrenia·2025· 9 citedOpen Access
Sample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia Program
Schizophrenia·2025· 8 citedOpen Access
The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program
Schizophrenia·2025· 6 citedOpen Access
Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample
Schizophrenia·2025· 7 citedOpen Access
Baseline Clinical Characterization of Participants in the Accelerating Medicines Partnership Schizophrenia Program
Schizophrenia Bulletin Open·2025Open Access
Sample Ascertainment and Recruitment Sources in the Accelerating Medicines Partnership Schizophrenia Program
Schizophrenia Bulletin Open·2025Open Access
Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis
UNC Libraries·2024Open Access
Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis
Schizophrenia Bulletin·2024· 65 citedOpen Access
36 Reactivity to Loss and Its Relationship to Clinical Symptoms of ADHD in Adults
Journal of the International Neuropsychological Society·2023Open Access
Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit
Schizophrenia Research·2020· 39 citedOpen Access
A Developmental Science Perspective on Vulnerability and Intervention for Youth Mental Health
The MIT Press eBooks·2020
Enhanced switching and familial susceptibility for psychosis
Brain and Behavior·2018· 2 citedOpen Access
Modeling Developmental Change Workshop 2017
OSF Preprints (OSF Preprints)·2017
Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users
Molecular Psychiatry·2016· 62 cited
Memory systems in schizophrenia: Modularity is preserved but deficits are generalized
Schizophrenia Research·2015· 7 cited
page 1 of 3Next →

Frequent Co-authors

Daniel H. Mathalon(21), Carrie E. Bearden(16), Jean Addington(14), Celso Arango(14), Kristin S. Cadenhead(14), Monica E. Calkins(14), Cheryl M. Corcoran(14), Lauren M. Ellman(14), Paolo Fusar‐Poli(14), Leslie E. Horton(14), Nikolaos Koutsouleris(14), Vijay A. Mittal(14), Jesús Pérez(14), Diana O. Perkins(14), Albert R. Powers(14), Jason Schiffman(14), Jai Shah(14), William S. Stone(14), Gregory P. Strauss(14), Daniel H. Wolf(14)